MET增强了阿米万他马布与EGFR的结合以及抗体依赖的细胞毒性
Shigeki Sato1,2, Neval Yilmaz3, Sachiko Arai3
1Department of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan.
Cancer science
|November 9, 2025
概括
阿米万塔马布是一种双特异性抗体,与EGFR和MET结合,增强其在非小细胞肺癌 (NSCLC) 的疗效. 增强MET可以增强AMIVANTAMAB.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 阿米万塔马布已批准用于治疗具有特定表皮生长因子受体 (EGFR) 突变的非小细胞肺癌 (NSCLC).
- 在EGFR结合和阿米万塔诱导的抗体依赖性细胞毒性 (ADCC) 中MET的作用尚未完全理解.
研究的目的:
- 调查阿米万塔马布与EGFR和MET相互作用的分子机制.
- 阐明MET对阿米万他马布疗效和NSCLC的ADCC的贡献.
主要方法:
- 高速原子力显微镜 (HS-AFM) 可视化阿米万塔与EGFR和MET细胞外域的实时结合.
- 西部斑点分析和凝过以评估阿米万塔马布-EGFR-MET复合体形成.
- 在NSCLC细胞中评估amivantamab诱导的ADCC,包括MET-knockout模型.
主要成果:
- 阿米万他马布与EGFR域3和MET Sema域结合,形成一个三元体复合体.
- MET增强了amivantamab与EGFR的结合,促进了三元体的形成.
- 阿米万塔马布在NSCLC细胞中诱导单核细胞介导的ADCC,这与EGFR表达有积极的相关性.
- MET显著增加ADCC活性,特别是在低度的阿米万他马布.
结论:
- MET在增强阿米万塔马布与EGFR的结合和增强ADCC方面发挥着至关重要的作用.
- 在患有常见EGFR突变的NSCLC患者中,MET有助于提高阿米万塔马布的疗效.
更多相关视频
11:02Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
Published on: September 14, 2018
8.1K
07:25In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
18.2K
相关概念视频
02:38Mitogens and the Cell Cycle
7.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K